Guidelines for the standard monitoring of patients with thalassemia: Report of the thalassemia longitudinal cohort

Venée N. Tubman, Ellen B. Fung, Maria Vogiatzi, Alexis A. Thompson, Zora R. Rogers, Ellis J. Neufeld, Janet L. Kwiatkowski

Research output: Contribution to journalArticle

16 Scopus citations


Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.

Original languageEnglish (US)
Pages (from-to)e162-e169
JournalJournal of Pediatric Hematology/Oncology
Issue number3
Publication statusPublished - Apr 7 2015



  • endocrinopathy
  • iron overload
  • thalassemia
  • transfusion
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this